Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease

A 62-year-old male with lung adenocarcinoma harboring an exon 19 deletion in the Epidermal growth factor receptor (EGFR) was treated with EGFR-tyrosine kinase inhibitors (TKIs) and several cytotoxic agents. After administering a fifth-line chemotherapy regimen, a liver biopsy revealed a diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiriu, Tatsunori, Tamura, Daisuke, Tachihara, Motoko, Sekiya, Reina, Hazama, Daisuke, Katsurada, Masahiro, Nakata, Kyosuke, Nagano, Tatsuya, Yamamoto, Masatsugu, Kamiryo, Hiroshi, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799064/
https://www.ncbi.nlm.nih.gov/pubmed/29033419
http://dx.doi.org/10.2169/internalmedicine.8947-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799064/
https://www.ncbi.nlm.nih.gov/pubmed/29033419
http://dx.doi.org/10.2169/internalmedicine.8947-17

Ejemplares similares